Conclusion: The study provided clinicians HES 200/0.5 solution as an option for treatment of DDS besides crystalloid, dextran because of its effects on hemodynamic, tissue perfusion, improved hemoconcentration and its safety on homeostasis including coagulation, electrolytes, acid-base balance.